ArticleExperimental and therapeutic medicine2026
Sagittal sinus thrombosis in pregnancy: A case report.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebral venous sinus thrombosis (CVST) is a rare but serious cause of maternal morbidity. It most frequently occurs during late pregnancy and puerperium, and occurs due to pregnancy-induced hypercoagulability. The present report documents a 37-year-old multiparous woman diagnosed with acute superior sagittal sinus thrombosis involving multiple dural sinuses at 6 weeks gestation. The patient was managed with therapeutic low-molecular-weight heparin (enoxaparin 100 mg twice daily) under multidisciplinary supervision throughout pregnancy; at 33 weeks, recurrent headaches and vomiting occurred, but imaging showed no new thrombosis. Delivery by elective cesarean section at 38 weeks resulted in a healthy neonate. Postpartum anticoagulation was transitioned to apixaban for 3 months with complete neurological recovery. Early diagnosis, appropriate anticoagulation and multidisciplinary management are key to favorable maternal and fetal outcomes in CVST during pregnancy. The present case report contributes to the literature that sagittal sinus thrombosis can present in early pregnancy with symptoms, such as headache and vomiting, which overlap with the normal symptoms of pregnancy; therefore, a high index of suspicion should be kept in mind.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.